A state-of-the-art food and drink incubator that will house pioneering future food and beverage businesses is set to open at Colworth Science Park in Bedford in the heart of the UK’s ‘Golden Triangle.’
Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief Commercial Officer and its first Managing Director.
Dr Francesca Sadler has joined MDC as Chief Commercial Officer, bringing over 20 years’ experience in commercialising high-quality scientific services to both UK and international communities.
Where Nordic life science meets the world
Nordic Life Science Days is the largest life science partnering event in the Nordics. NLSDays gathers big pharma executives, investors and CEOs of biotech, pharma and medtech companies and discusses the road ahead for the life science industry. 2024 numbers: • Attracted 1400+ delegates from 30 countries. • Gathered 150+ investors and 120+ speakers and presenters • Gathered 130+ showcasing companies, organizations, and countries. • Enjoyed the support of more than 80 sponsors and partners.
EZ-Spread™ Plating Beads from AMSBIO allow you to spread bacterial and yeast cells across the surface of an agar plate in just seconds.
Eliminating the traditional need for glass rods and potentially hazardous ethanol flaming - EZ-Spread plating beads provide a safer and more convenient method for spreading bacterial and yeast cells on agar plates.
Manufactured using precision molds, resulting in uniform shape and diameter, EZ-Spread plating beads ensure more even spreading of cells leading to increased colony formation compared to conventional methods.
Cancer Research Horizons, the innovation arm of Cancer Research UK, has opened nominations for its Innovation and Entrepreneurship Awards 2025, which celebrate the UK’s most enterprising efforts in oncology by recognising the researchers and entrepreneurs who are making strides towards translating their innovations into effective treatments and diagnostics for the benefit of patients affected by cancer.
The event to discover, collaborate, and invest in the success of UK & Nordic life sciences.
The Annual Anglonordic Life Science Conference is back for 2025. Join us on the 3rd April for the 21st edition of this must-attend conference. You will have opportunities to:
OXFORD, UK – 8 January 2025 – PrecisionLife, a leading precision medicine company focused on complex chronic diseases, announces the appointment of Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare to lead the commercialization of precision medicine applications from its range of innovative new Mechanostic® tests in complex chronic diseases.
iBoxit, KNEE3D and PfBIO have been named winners at a competition showcasing innovative business ideas at Norwich Research Park.
In collaboration with the University of East Anglia (UEA) and The Royal Society, the Innovation Hothouse competition saw eight finalists pitch their innovative ideas to a panel of expert judges.
All were either spin-out or start-up companies founded by researchers, scientists, entrepreneurs or students based on the park campus.
This webinar will feature an academic case study on NaV1.9 as a drug target by Professor David Bulmer (University of Cambridge). The webinar will also include a presentation by Metrion CSO, Dr. Eddy Stevens with an overview of Metrion’s newly developed NaV1.9 screening assays.
A recent study published in the Journal of Pharmaceutical Sciences (https://doi.org/10.1016/j.xphs.2024.10.013) analysed the complexities of three-dimensional crystal packing arrangements of small-molecule drug candidates, focusing on the CCDC Solid Form Health Check to assess the risk of thermodynamically stable solid forms during drug development.